Hong Bin Zhou

Hong Bin Zhou is currently the Co-Chief Investment Officer & Managing Director at Legend Capital Co. Ltd., the Director at MicuRx Pharmaceuticals, Inc., the Director at Milkyway Intelligent Supply Chain Service Group Co., Ltd., the Non-Executive Director at Jiangsu Recbio Technology Co., Ltd., the Director at Shanghai Atour Business Management Group Co., Ltd., the Director at Joy Wing Mau Corp.
Ltd., the Director at Atour Lifestyle Holdings Ltd., the Director at Ningbo Xinwan Technology Development Co. Ltd., the Director at China Southern Airlines Cargo Logistics Guangzhou Co. Ltd., and the Non-Executive Director at Shanghai Cell Therapy Group Co., Ltd.
Formerly, Dr. Zhou served as the Chairman-Supervisory Board at Shanghai Genext Medical Technology Co., Ltd., the Non-Executive Director at Pharmaron Beijing Co., Ltd., the Director at Jiangsu Lihua Animal Husbandry Co., Ltd., the Director at Chemclin Diagnostics Co., Ltd., the Director at Shanghai MicuRx Pharmaceutical Co., Ltd., and a Member-Supervisory Board at Guangzhou Kingmed Diagnostics Group Co., Ltd.Dr. Zhou obtained a graduate degree from Wuhan University in 1997, an undergraduate degree from Wuhan University in 1994, and a doctorate degree from Fudan University in 2000.